In this study, we examined Her2+ breast cancer cells, in which we found that p27 was mislocalized in the cytoplasm, and this finding is supported by Andre et al., who reported that a low p27 nuclear/cytoplasmic ratio correlated with Her2 expression in human breast cancer [30]. The gene discussed is ERBB2; the disease is breast carcinoma.